> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Broaden Cancer Trial Eligibility: Advocates
- URL: https://www.fdaweb.com/broaden-cancer-trial-eligibility-advocates/
- Published: 2021-02-09T12:00:00.000Z
- Updated: 2026-09-14T16:45:59.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5148620

The American Society of Clinical Oncology and Friends of Cancer Research are recommending ways to further efforts to broaden eligibility criteria in cancer clinical trials. In a [statement](ttps://www.asco.org/about-asco/press-center/news-releases/asco-and-friends-cancer-research-recommend-expanding-patient), the two groups say their goal is to make clinical trials more accessible to patients.

The joint recommendations are contained in a series of articles published in *Clinical Cancer Research*, a journal of the American Association for Cancer Research.

“The series provides a comprehensive examination of eligibility criteria for cancer clinical trials with recommendations to address five specific areas: treatment washout periods, concomitant medications, prior therapies, laboratory reference ranges and test intervals, and patient performance status,” the statement says.